rs878853454
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000038.6(APC):c.5025dupT(p.Arg1676fs) variant causes a frameshift, stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000038.6 frameshift, stop_gained
Scores
Clinical Significance
Conservation
Publications
- classic or attenuated familial adenomatous polyposisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- desmoid tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- familial adenomatous polyposis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- gastric adenocarcinoma and proximal polyposis of the stomachInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- APC-related attenuated familial adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Turcot syndrome with polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| APC | NM_000038.6 | c.5025dupT | p.Arg1676fs | frameshift_variant, stop_gained | Exon 16 of 16 | ENST00000257430.9 | NP_000029.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| APC | ENST00000257430.9 | c.5025dupT | p.Arg1676fs | frameshift_variant, stop_gained | Exon 16 of 16 | 5 | NM_000038.6 | ENSP00000257430.4 | ||
| ENSG00000258864 | ENST00000520401.1 | n.228+11647dupT | intron_variant | Intron 3 of 7 | 3 | ENSP00000454861.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 66
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:2
This sequence change inserts 1 nucleotide in exon 16 of the APC mRNA (c.5025dupT), causing a frameshift at codon 1676. This creates a premature translational stop signal in the last exon of the APC mRNA (p.Arg1676*). While this is not anticipated to result in nonsense mediated decay, it is expected to remove the final ~1150 amino acid residues of APC, which is equivalent to ~40% of the total protein. While this particular variant has not been reported in the literature, numerous pathogenic truncating variants have been reported downstream of this c.5025dupT variant in individuals affected with classical familial adenomatous polyposis (FAP), attenuated FAP, or desmoid tumor, suggesting that the C-terminal portion of the protein is clinically important (PMID: 23159591, 8940264, 9824584, 8968744). For these reasons, this variant has been classified as Pathogenic.
For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, numerous pathogenic truncating variants have been reported downstream of this c.5025dupT variant in individuals affected with classical familial adenomatous polyposis (FAP), attenuated FAP, or desmoid tumor, suggesting that the C-terminal portion of the protein is clinically important (PMID: 23159591, 8940264, 9824584, 8968744). This sequence change inserts 1 nucleotide in exon 16 of the APC mRNA (c.5025dupT), causing a frameshift at codon 1676. This creates a premature translational stop signal in the last exon of the APC mRNA (p.Arg1676*). While this is not anticipated to result in nonsense mediated decay, it is expected to remove the final ~1150 amino acid residues of APC, which is equivalent to ~40% of the total protein.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at